Sohaib Mir Ph.D Overview
- Firm
- LifeArc
- Primary Position
-
Senior Investmen...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Sohaib Mir Ph.D General Information
Biography
Dr. Sohaib Mir serves as Senior Investment Principal at LifeArc Ventures. He serves as a Board Member at Maxion Therapeutics. He served as a Board Member at Montis Biosciences and Pheno Therapeutics. He brings more than 10 years of experience across investment banking and venture capital following a career in medicine. He was an Investment Director with ALSA Ventures, focused on therapeutics investing, a Principal at Cambridge Innovation Capital, and worked in healthcare M&A with Perella Weinberg Partners. He qualified in Medicine from the University of Birmingham where he also completed a PhD. He practiced medicine at Addenbrooke's Hospital in Cambridge and gained an MPhil in Bioscience Enterprise from the University of Cambridge.
Contact Information
Address
- Lynton House
- 7-12 Tavistock Square
- London WC1H 9LT
- England, United Kingdom
Sohaib Mir Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
LifeArc | Investor | Senior Investment Principal | London, United Kingdom | Venture Capital | |
LifeArc Ventures | Investor | Senior Investment Principal | London, United Kingdom | Venture Capital |
Sohaib Mir Ph.D Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Maxion Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, United Kingdom | |
Pheno Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Edinburgh, United Kingdom |
Sohaib Mir Ph.D Lead Partner on Deals (3)
Sohaib Mir Ph.D has been the lead partner on 3 deals. Their latest deal was with Maxion Therapeutics, a drug discovery company. The deal was made for on 03-Feb-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Maxion Therapeutics | 03-Feb-2023 | Early Stage VC | Completed | Drug Discovery | Cambridge, United Kingdom | |
Montis Biosciences | 01-Mar-2021 | Completed | Drug Discovery | Leuven, Belgium | ||
Pheno Therapeutics | 29-Mar-2020 | Completed | Drug Discovery | Edinburgh, United Kingdom |
Sohaib Mir Ph.D Network (58)
Board Members (31)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Ian Tomlinson Ph.D | Maxion Therapeutics | Self | Cambridge, United Kingdom | |
Robert Tansley | Exvastat | Cambridge Innovation Capital | Cambridge, United Kingdom | |
Pheno Therapeutics | Pheno Therapeutics | Edinburgh, United Kingdom | ||
Maxion Therapeutics | Monograph Capital | Cambridge, United Kingdom | ||
Maxion Therapeutics | Monograph Capital | Cambridge, United Kingdom |
Portfolio Executives (15)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Arndt Schottelius Ph.D | Maxion Therapeutics | Co-Chief Executive Officer | 03-Feb-2023 | Cambridge, United Kingdom |
Aneesh Vellatt Ph.D | Maxion Therapeutics | Co-Founder, Chief Scientific Officer & Board Member | 03-Feb-2023 | Cambridge, United Kingdom |
Maxion Therapeutics | Co-Founder & Chief Technology Officer | 03-Feb-2023 | Cambridge, United Kingdom | |
Montis Biosciences | Chief Executive Officer | 01-Mar-2021 | Leuven, Belgium | |
Montis Biosciences | Acting Chief Medical Officer | 01-Mar-2021 | Leuven, Belgium |
Fund Team Members (12)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Robert Balfour Ph.D | ALSA Ventures | ALSA Ventures Fund I | London, United Kingdom |
Jonathan Nash | LifeArc Ventures | LifeArc Ventures | London, United Kingdom |
ALSA Ventures | London, United Kingdom | ||
ALSA Ventures | London, United Kingdom | ||
ALSA Ventures | London, United Kingdom |
Sohaib Mir Ph.D Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
LifeArc Ventures | LifeArc Ventures | Venture Capital - Early Stage | Evergreen | |||||
ALSA Ventures Fund I | ALSA Ventures | Venture - General | Closed | 2020 |
Sohaib Mir Ph.D FAQs
-
Who is Sohaib Mir Ph.D?
Dr. Sohaib Mir serves as Senior Investment Principal at LifeArc Ventures.
-
How much does Sohaib Mir Ph.D typically invest?
Sohaib Mir Ph.D's median deal size is
. -
What is Sohaib Mir Ph.D’s main position?
Sohaib Mir Ph.D’s primary position is Senior Investment Principal.
-
What are the contact details for Sohaib Mir Ph.D?
Sohaib Mir Ph.D’s email address is so
and his phone number is +44 01223 . -
How many active board seats does Sohaib Mir Ph.D hold?
Sohaib Mir Ph.D holds 2 board seats including Maxion Therapeutics and Pheno Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »